Postnatal thyroid hormones for respiratory distress syndrome in preterm infants

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2007, Pages

  Osborn, David A ^a   Hunt, R W ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b NONE

Author keywords

Humans; Infant, newborn; Infant, premature; Respiratory distress syndrome, newborn *drug therapy ; Thyroid hormones *therapeutic use ; Thyroxine therapeutic use ; Triiodothyronine therapeutic use

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; PROTIRELIN; THYROID HORMONE;

ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; EMBASE; HUMAN; LIOTHYRONINE BLOOD LEVEL; MEDLINE; META ANALYSIS; NECROTIZING ENTEROCOLITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; OUTCOMES RESEARCH; PATENT DUCTUS ARTERIOSUS; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 44949135029     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005946.pub2     Document Type: Review

References (46)

1. Amato 1988 {published data only} Amato M, Pasquier S, Carasso A, Von Muralt G. Postnatal thyroxine administration for idiopathic respiratory distress syndrome in preterm infants. Hormone Research 1988;29:27-30.
2. Amato 1989 {published data only} Amato M, Guggisberg C, Schneider H. Postnatal triiodothyronine replacement and respiratory distress syndrome of the preterm infant. Hormone Research 1989;32:213-7.
3. Bettendorf 2000 Bettendorf M, Schmidt KG, Grulich-Henn J, Ulmer HE, Heinrich UE. Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study. Lancet 2000;356:529-34.
4. Biswas 2003 Biswas S, Buffery J, Enoch H, Bland JM, Walters D, Markiewicz M. A longitudinal assessment of thyroid hormone concentrations in preterm infants younger than 30 weeks' gestation during the first 2 weeks of life and their relationship to outcome. Pediatrics 2002;109:222-7.
5. *Biswas S, Buffery J, Enoch H, Bland M, Markiewicz M, Walters D. Pulmonary effects of triiodothyronine (T3) and hydrocortisone (HC) supplementation in preterm infants less than 30 weeks gestation: results of the THORN trial - thyroid hormone replacement in neonates. Pediatric Research 2003;53:48-56.
6. Cassio A 2003 Cassio A, Cacciari E, Cicognani A, Damiani G, Missiroli G, Corbelli E, Balsamo A, Bal M, Gualandi S. Treatment for congenital hypothyroidism: thyroxine alone or thyroxine plus triiodothyronine?. Pediatrics 2003;111:1055-60.
7. Chowdhry 1984 Chowdhry P, Scanlon JW, Auerbach R, Abbassi V. Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia. Pediatrics 1984;73:301-5.
8. Chowdhury 2001 Chowdhury D, Ojamaa K, Parnell VA, McMahon C, Sison CP, Klein I. A prospective randomized clinical study of thyroid hormone treatment after operations for complex congenital heart disease. Journal of Thoracic & Cardiovascular Surgery 2001;122:1023-5.
9. Eggermont 1984 Eggermont E, Vanderschueren Lodeweyckx M, De Nayer P, Smeets E, Vanacker G, Cornette C, Jaeken J, Devlieger H, Eeckels R, Beckers C. The thyroid-system function in preterm infants of postmenstrual ages of 31 weeks or less: evidence for a "transient lazy thyroid system". Helvetica Paediatrica Acta 1984;39:209-22.
10. Schonberger 1981 Schonberger W, Grimm W, Emmrich P, Gempp W. Reduction of mortality rate in premature infants by substitution of thyroid hormones. European Journal of Pediatrics 1981;135:245-53.
11. Selva 2002 Selva KA, Mandel SH, Rien L, Sesser D, Miyahira R, Skeels M, Nelson JC, Lafranchi SH. Initial treatment dose of L-thyroxine in congenital hypothyroidism. Journal of Pediatrics 2002;141:786-92.
12. Smith 2000 Smith LM, Leake RD, Berman N, Villanueva S, Brasel JA. Postnatal thyroxine supplementation in infants less than 32 weeks' gestation: effects on pulmonary morbidity. Journal of Perinatology 2000;20:427-31.
13. Valerio 2004 *Valerio PG, van Wassenaer AG, de Vijlder JJ, Kok JH. A randomized, masked study of triiodothyronine plus thyroxine administration in preterm infants less than 28 weeks of gestational age: hormonal and clinical effects. Pediatric Research 2004;55:248-53.
14. Valerio PG, van Wassenaer AG, Kok JH. A randomized, masked study of T3 plus T4 administration in preterm infants less than 28 weeks of gestational age: hormonal and clinical effects. Pediatric Research. 2002; Vol. 51:125A.
15. van Wassenaer 1993 van Wassenaer AG, Kok JH, Endert E, Vulsma T, de Vijlder JJ. Thyroxine administration to infants of less than 30 weeks' gestational age does not increase plasma triiodothyronine concentrations. Acta Endocrinologica 1993;129:139-46.
16. van Wassenaer 1997 Briet JM, van Wassenaer AG, Dekker FW, de Vijlder JJ, van Baar A, Kok JH. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age. Pediatrics 2001;107:712-8.
17. Briet JM, van Wassenaer AG, van Baar A, Dekker FW, Kok JH. Evaluation of the effect of thyroxine supplementation on behavioural outcome in very preterm infants. Developmental Medicine and Child Neurology 1999;41:87-93.
18. Smit BJ, Kok JH, de Vries LS, van Wassenaer AG, Dekker FW, Ongerboer de Visser BW. Motor nerve conduction velocity in very preterm infants in relation to L-thyroxine supplementation. Journal of Pediatrics 1998;132:64-9.
19. Smit BJ, Kok JH, de Vries LS, van Wassenaer AG, Dekker FW, Ongerboer de Visser BW. Somatosensory evoked potentials in very preterminfants in relation to L-thyroxine supplementation. Pediatrics 1998;101:865-9.
20. van Wassenaer, Kok JH, Dekker FW, de Vijlder JJ. Thyroid function in very preterm infants: influences of gestational age and disease. Pediatric Research 1997;42:604-9.
21. van Wassenaer AG, Briët JM, van Baar A, Smit BJ, Tamminga P, de Vijlder JJM, Kok JH. Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infants. Pediatrics 2002;109:534-9.
22. Van Wassenaer AG, Kok JH, Briet JM, Pijning AM, de Vijlder JJ. Thyroid function in very preterm newborns: possible implications. Thyroid 1999;9(85-91).
23. van Wassenaer AG, Kok JH, Briet JM, van Baar A, de Vijlder JJ. Thyroid function in preterm newborns; is T4 treatment required in infants <27 weeks' gestational age?. Experimental and clinical endocrinology & diabetes 1997;105:12-8.
24. van Wassenaer AG, Kok JH, Dekker FW, Endert E, de Vijlder JJ. Thyroxine administration to infants of less than 30 weeks gestational age decreases plasma tri-iodothyronine concentrations. European Journal of Endocrinology 1998;139:508-15.
25. *van Wassenaer AG, Kok JH, de Vijlder JJ, Briet JM, Smit BJ, Tamminga P, van Baar A, Dekker FW, Vulsma T. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. The New England Journal of Medicine 1997;336:21-6.
26. Vanhole 1997 Vanhole C, Aerssens P, Devlieger H, de Zegher F. L-Thyroxine treatment of preterm newborns. Pediatric Research 1996;40:555.
27. *Vanhole C, Aerssens P, Naulaers G, Casneuf A, Devlieger H, Van den Berghe G, de Zegher F. L-thyroxine treatment of preterm newborns: clinical and endocrine effects. Pediatric Research 1997;42:87-92.
28. Golombek Hypothyroxemia trial. Ongoing study To be announced.
29. Abbassi 1977 Abbassi V, Merchant K, Abramson D. Postnatal triiodothyronine concentrations in healthy preterm infants and in infants with respiratory distress syndrome. Pediatric Research 1977;11:802-4.
30. Ballard 1992 Ballard PL, Ballard RA, Creasy RK, Padbury J, Polk DH, Bracken M, et al.Plasma thyroid hormones and prolactin in premature infants and theirmothers after prenatal treatment with thyrotropin-releasing hormone. Pediatric Research 1992;32:673-8.
31. Belet 2003 Belet N, Imdat H, Yanik F, Kucukoduk S. Thyroid function tests in preterm infants born to preeclamptic mothers with placental insufficiency. Journal of Pediatric Endocrinology 2003;16:1131-5.
32. Bernal 1984 Bernal J, Pekonen F. Ontogenesis of the nuclear 3,5,3′-triiodothyronine receptor in the human fetal brain. Endocrinology 1984;114:677-9.
33. Crowley 1996 Crowley P. Prophylactic corticosteroids for preterm birth. The Cochrane Database of Systematic Reviews 1996, Issue 1.Art. No.: CD000065. DOI:10.1002/14651858.CD000065.pub2.
34. Crowther 2004 Crowther CA, Alfirevic Z, Haslam RR. Thyrotropin-releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. The Cochrane Database of Systematic Reviews 2004, Issue 2.Art. No.: CD000019. DOI:10.1002/14651858.CD000019.pub2.
35. Keijzer 2000 Keijzer R, van Tuyl M, Tibboel D. Hormonal modulation of fetal pulmonary development: relevance for the fetus with diaphragmatic hernia. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2000;92:127-33.
36. Laws 2004 Laws PJ, Sullivan EA. Australia's mothers and babies 2002. AIHW Cat. No. PER 28. Sydney: AIHW National Perinatal Statistics Unit (Perinatal Statistics Series No. 15) 2004.
37. Oden 2002 Oden J, Freemark M. Thyroxine supplementation in preterm infants: critical analysis. Current Opinion in Pediatrics 2002;14:447-52.
38. Ogilvy-Stuart 2002 Ogilvy-Stuart AL. Neonatal thyroid disorders. Archives of Disease in Childhood Fetal and Neonatal Edition 2002;87:F165-71.
39. Osborn 2001 Osborn DA. Thyroid hormones for preventing neurodevelopmental impairment in preterm infants. Cochrane Database of Systematic Reviews 2001, Issue 4.Art. No.: CD001070. DOI:10.1002/14651858. CD001070.
40. Osborn 2007a Osborn DA, Hunt RW. Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 2007, Issue 1.Art. No.: CD005948. DOI:10.1002/14651858.CD005948.pub2.
41. Osborn 2007b Osborn DA, Hunt RW. Postnatal thyroid hormones for preterm infants with transient hypothyroxinaemia. Cochrane Database of Systematic Reviews 2007, Issue 1.Art. No.: CD005945. DOI:10.1002/14651858. CD005945.pub2.
42. Roberts 2006 Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2006, Issue 3.Art. No.: CD004454. DOI:10.1002/14651858.CD004454.pub2.
43. Romaguera 1993 Romaguera J, Ramirez M, Adamsons K. Intra-amniotic thyroxine to accelerate fetal maturation. Seminars in Perinatology 1993;17:260-6.
44. Schellenberg 1987 Schellenberg JC, Liggins GC. New approaches to hormonal acceleration of fetal lung maturation. Journal of Perinatal Medicine 1987;15:447-52.
45. Smith 1983 Smith DM, Hitchcock KR. Thyroid hormone binding to adult rat alveolar type II cells. An autoradiographic study. Experimental Lung Research 1983;5:141-53.
46. van Wassenaer 1997 van Wassenaer AG, Kok JH, Dekker FW, de Vijlder JJ. Thyroid function in very preterm infants: influences of gestational age and disease. Pediatric Research 1997;42:604-9.